Published in Medicine and Law Weekly, August 25th, 2006
Those results are as follows:
Consolidated operating results from continuing operations:
- Revenue increased 10% to $250 million
- Diluted EPS from continuing operations of $.48
- Adjusted diluted EPS from Continuing Operations,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.